Announcements Trials
Browse Landscape

Phase

Phase 3 2Phase 2 2Phase 1/2 1

Status

Completed 4Terminated 1

Sponsor Class

OTHER 4INDUSTRY 1

Study Type

Interventional 5

Sponsor

Cancer Type

Genitourinary 5

Conditions

Prostatic Neoplasms 1106Carcinoma, Renal Cell 412Urinary Bladder Neoplasms 280Kidney Neoplasms 177Neoplasm Metastasis 134Neoplasms 132Carcinoma, Non-Small-Cell Lung 109Carcinoma, Transitional Cell 108Breast Neoplasms 94Melanoma 90Ovarian Neoplasms 70Lung Neoplasms 67Colorectal Neoplasms 58Pancreatic Neoplasms 49Sarcoma 48Wilms Tumor 41Uterine Cervical Neoplasms 37Head and Neck Neoplasms 37Stomach Neoplasms 36Testicular Neoplasms 33Non-Muscle Invasive Bladder Neoplasms 33Esophageal Neoplasms 33Squamous Cell Carcinoma of Head and Neck 31Neuroblastoma 30Lymphoma, Non-Hodgkin 29Colonic Neoplasms 28Small Cell Lung Carcinoma 27Carcinoma, Hepatocellular 27Urethral Neoplasms 25Triple Negative Breast Neoplasms 23

Interventions

sipuleucel-T 1pazopanib 1enzalutamide 1Radiotherapy 1Androgen Antagonists 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Has results × Adenocarcinoma of the Prostate × Genitourinary × Clear all
NCT01517451 2026-02-11

Radiation and Androgen Ablation for Prostate Cancer

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Phase 1/2 Completed
45 enrolled 11 charts
Genitourinary

Adenocarcinoma of the Prostate

NCT02203695 2025-10-28

Randomized Salvage Radiation Therapy Plus Enzalutamide Post Prostatectomy

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Phase 2 Completed
86 enrolled 13 charts
Genitourinary

Adenocarcinoma of the Prostate

NCT03686683 2024-10-08

ProVent

Dendreon

Phase 3 Completed
532 enrolled 14 charts
Genitourinary

Adenocarcinoma of the Prostate

NCT03535675 2023-05-22

Muscadine Plus (MPX) In Men With Prostate Cancer

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Phase 3 Terminated
59 enrolled 9 charts
Genitourinary

Adenocarcinoma of the Prostate

NCT01832259 2018-12-12

A Study of VEGF Tyrosine Kinase Inhibitor (Pazopanib) in Men With High-Risk Prostate Cancer Followed by Radical Prostatectomy and Pelvic Lymph Node Dissection

University of Utah

Phase 2 Completed
30 enrolled 10 charts
Genitourinary

Adenocarcinoma of the Prostate

Data powered by HemOnc (CC BY 4.0) Colophon âš¡